Eczematous and Papulosquamous Disorders

Neonatal Dermatology

Volumn , Issue , 2008, Pages 229-244

  Bernard, Laurie A ^a,b   Eichenfield, Lawrence F ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84937227481     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3432-2.50018-2     Document Type: Chapter

References (116)

1. E Besnier (1892) Premiere note et observations preliminaires pour servir d'introduction a l'étude diathesques. Ann Dermatol Syphiligr 4 634.
2. F Wise and MB Sulzberger (1933) Editorial remarks. Year book of dermatology and syphilology Chicago: Year Book Medical Publishers 59.
3. LW Hill and MR Sulzberger (1935) Evolution of atopic dermatitis. Arch Derm Syphilol 32 451-463.
4. JC Su, AS Kemp, GA Varigos and TM Nolan (1997) Atopic eczema: its impact on the family and financial cost. Arch Dis Child 76 159-162.
5. DR Bickers, HW Lim, D Margolis, et al. (2006) The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol 55 490-500.
6. RB Walker and RP Warin (1956) The incidence of eczema in early childhood. Br J Dermatol 68 182.
7. CL Carroll, R Balkrishnan, SR Feldman, et al. (2005) The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol 22 192-199.
8. Y Tay, H Kong, L Koo, et al. (2002) The prevalence and descriptive epidemiology of atopic dermatitis in Singapore school children. Br J Dermatol 146 101-106.
9. HC Williams, DP Strachan and RJ Hay (1994) Childhood eczema: disease of the advantaged? Br Med J 308 1132-1135.
10. T Schafer, P Dirschedl, B Kunz, et al. (1997) Maternal smoking during pregnancy and lactation increases the risk for atopic eczema in the offspring. J Am Acad Dermatol 36 550-556.
11. TJ David and CI Ewing (1988) Atopic eczema and preterm birth. Arch Dis Child 63 435-436.
12. LF Eichenfield, JM Hanifin, LA Beck, et al. (2004) Atopic dermatitis and asthma: parallels in the evolution of treatment. Pediatrics 111 608-616.
13. C Queille-Roussel, F Raynaud and J-H Saurat (1985) A prospective computerized study of 500 cases of atopic dermatitis in childhood. Acta Dermatol Venereol 114 87-92.
14. G Rajka (1989) Essential aspects of atopic dermatitis Berlin: Springer-Verlag 21.
15. W Kuster, M Peterson, E Christophers, et al. (1990) A family study of atopic dermatitis: Clinical and genetic characteristics of 188 patients and 2,151 family members. Arch Dermatol Res 282 98-102.
16. J Hanifin and G Rajka (1980) Diagnostic features of atopic dermatitis. Acta Dermatol Venereol 92 44.
17. HC Williams, PG Burney, RJ Hay, et al. (1994) The UK Working Party's diagnostic criteria for atopic dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 131 383-396.
18. LF Eichenfield, JM Hanifin, TA Luger, et al. (2003) Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol 49 1088-1095.
19. H Uno and JM Hanifin (1979) Ultrastructural and L-dopa histofluorescent observations of Langerhans' cells in atopic dermatitis. Clin Res 27 538A.
20. H Montgomery (1967) Dermatopathology Vol. 1 New York: Harper & Row 186-190.
21. NA Soter and MC Mihm Jr (1980) Morphology of atopic eczema. Acta Dermatol Venereol 92 11.
22. D Tobin, G Nabarro, H Baart de la Faille, et al. (1992) Increased number of immunoreactive nerve fibers in atopic dermatitis. J Allergy Clin Immunol 90 613-622.
23. MC Mihm, NA Soter, HF Dvorak and KF Austen (1976) The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 67 305-312.
24. D Leung, M Boguniewicz, M Howell, et al. (2004) New insights into atopic dermatitis. J. Clin Invest 113 651.
25. F Schultz Larsen (1993) Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 28 719-723.
26. A Bellou, G Kanny, S Fremont, et al. (1997) Transfer of atopy following bone marrow transplantation. Ann Allergy Asthma Immunol 78 513-516.
27. WOCM Cookson, PA Sharp, JA Faux and JM Hopkin (1989) Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q. Lancet 10 1292-1295.
28. T Shirakawa, T Hashimoto, J Furuyama, et al. (1994) Linkage between severe atopy and chromosome 11q13 in Japanese families. Clin Genet 46 228-232.
29. DG Marsh and DA Meyers (1992) A major gene for allergy — fact or fancy? Nature Genet 2 252-254.
30. R Coleman, RC Trembath and JI Harper (1993) Chromosome 11q13 and atopy underlying atopic eczema. Lancet 341 1121-1122.
31. MN Blumenthal (1997) The role of genetic factors in determining atopic conditions. Can J Allergy Clin Immunol 2 69.
32. P Juto and O Strannegard (1979) T lymphocytes and blood eosinophils in early infancy in relation to heredity for allergy and type of feeding. J Allergy Clin Immunol 64 38-42.
33. JM Butler, SC Chan, S Stevens and JM Hanifin (1983) Increased leukocyte histamine release with elevated cyclic AMP-phosphodiesterase activity in atopic dermatitis. J Allergy Clin Immunol 71 490-497.
34. MJ Cork, DA Robinson, Y Vasilopoulos, et al. (2006) New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J. Allergy Clin Immunol 118 3-21.
35. H Sugiura, H Ebise, T Tazawa, et al. (2005) Large-scale DNA microarray analysis of atopic skin lesions shows overexpression of an epidermal differentiation gene cluster in the alternative pathway and lack of protective gene expression in the cornified envelope. Br J Dermatol 152 146.
36. LY McGirt and LA Beck (2006) Innate immune defects in atopic dermatitis. J Allergy Clin Immunol 118 202-208. Epub 2006 Jun 6
37. Q Hamid, M Boguniewicz and D Leung (1994) Differential in in situ cytokine gene expression in acute vs chronic dermatitis. J Clin Invest 94 870.
38. B Homey, M Steinhoff, T Ruzicka and DY Leung (2006) Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 118 178-189.
39. A Giannetti, F Fantini, A Cimitan and C Pincelli (1992) Vasoactive intestinal polypeptide and substance P in the pathogenesis of atopic dermatitis. Acta Dermatol Venereol 176 90-92.
40. KD Cooper (1993) Atopic dermatitis: Recent trends in pathogenesis and therapy. Prog Dermatol 27 1-16.
41. N Novak and T Bieber (2005) The role of dendritic cell subtypes in the pathophysiology of atopic dermatitis. J Am Acad Dermatol 53 S171-S176.
42. D Debra Rowlands, SJ Tofte and JM Hanifin (2006) Does food allergy cause atopic dermatitis? Food challenge testing to dissociate eczematous from immediate reactions. Dermatol Ther 19 97-103.
43. N Sigurs, G Hattevig and B Kjellman (1992) Maternal avoidance of eggs, cow's milk, and fish during lactation:effect on allergic manifestations, skin-prick tests, and specific IgE antibodies in children at age 4 years. Pediatrics 89 735-739.
44. HA Sampson and DD Metcalfe (1992) Food allergies. JAMA 268 2840-2844.
45. JM Hanifin (1997) Critical evaluation of food and mite allergy in the management of atopic dermatitis. J Dermatol 24 495-503.
46. DY Leung, R Harbeck, P Bina, et al. (1993) Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. J Clin Invest 92 1374-1380.
47. S Illi, E von Mutius, S Lau, et al. (2004) The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 113 925-931.
48. CFH Vickers (1980) The natural history of atopic eczema. Presented at International Symposium on Atopic Dermatitis 1979. Acta Dermatol Venereol 92 113.
49. JN Barker, CN Palmer, Y Zhao, et al. (2006) Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Invest Dermatol [Epub ahead of print]
50. ML Lubs (1972) Empiric risks for genetic counseling in families with allergy. J Pediatr 80 26-31.
51. CN Palmer, AD Irvine, A Terron-Kwiatkowski, et al. (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nature Genet 38 441-446.
52. DYM Leung and M Boguniewicz (2004) Triggers of atopic dermatitis. LF Eichenfield, DYM Leung (Eds) The eczemas New York: Summit Communications 55-63.
53. C Hoare, A Li Wan Po and H Williams (2000) Systematic review of treatments for atopic eczema. Health Technol Assess 4 1-191.
54. J Berth-Jones and RA Graham-Brown (1989) Failure of terfenadine in relieving the pruritus of atopic dermatitis. Br J Dermatol 121 635-637.
55. AW Lucky, AD Leach, P Laskarzewski and H Wenck (1997) Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol 14 321-324.
56. SL Chamlin, J Kao, IJ Frieden, et al. (2002) Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 47 198.
57. W Abramovits and M Boguniewicz (2006) A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults. J Drugs Dermatol 5 236.
58. MB Sulzberger and VH Witten (1952) The effect of topically applied compound F in selected dermatoses. J Invest Dermatol 101-102.
59. K Yamamoto (1989) How doctor's advice is followed by mothers of atopic children. Acta Dermatol Venereol 144 31-33.
60. CR Charman, AD Morris and HC Williams (2000) Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 142 931-936.
61. J Callen, S Chamlin, L Eichenfield, et al. (2007) A systematic review of the safety of topical therapies for atopic dermatitis. Br J Dermatol 156(2), 203-221.
62. LF Eichenfield (2004) Consensus guidelines in diagnosis and treatment of atopic dermatitis. Allergy 59 86-92.
63. A Kapp, K Papp, A Bingham, et al. (2002) Flare Reduction in Eczema with Elidel (infants) Multicentre Investigator Study Group: long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug. J Allergy Clin Immunol 110 277-284.
64. D Whalley, J Huels, SP McKenna and D van Assche (2002) The benefit of pimecrolimus (Elidel, SDZ ASM 981) on parents' quality of life in the treatment of pediatric atopic dermatitis. Pediatrics 110 1133-1136.
65. VC Ho, A Gupta, R Kaufmann, et al. (2003) Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants. J Pediatr 142 155-162.
66. R Kaufmann, R Fölster-Holst, P Höger, et al. (2004) Onset of action of pimecrolimus cream 1% in the treatment of atopic eczema in infants. J Allergy Clin Immunol 114 1183-1188.
67. KA Papp, T Werfel, R Fölster-Holst, et al. (2005) Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children:a two-year study. J Am Acad Dermatol 52 240-246.
68. KA Papp, K Breuer, M Meurer, et al. (2005) Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination. J Am Acad Dermatol 52 247-253.
69. RAC Graham-Brown and M Grassberger (2003) Pimecrolimus: a review of pre-clinical and clinical data. Int J Clin Pract 57 319-327.
70. BR Allen, M Lakhanpaul, A Morris, et al. (2003) Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients. Arch Dis Child 88 969-973.
71. M Lakhanpaul, T Davies, B Allen, et al. (2002) Pimecrolimus (SDZ ASM 981) cream 1%: minimal systemic absorption in infants with atopic dermatitis during long-term treatment [abstract]. Ann Dermatol Venereol 129 415.
72. TG Berger, M Duvic, AS Van Voorhees, et al. (2006) The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force. J Am Acad Dermatol 54 818.
73. C Paul, M Cork, AB Rossi, et al. (2006) Safety and tolerability of 1% pimecrolimus cream among infants:experience with 1133 patients treated for up to 2 years. Pediatrics 117 e118.
74. EJ Nilsson, CG Henning and J Magnusson (1992) Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol 27 29-34.
75. R Lever, K Hadley, D Downey and R Mackie (1988) Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 119 189-198.
76. MV Dahl (1983) Staphylococcus aureus and atopic dermatitis. Arch Dermatol 119 840-846.
77. M Kalliomaki, S Salminen, H Arvilommi, et al. (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357 1076.
78. M Kalliomaki, S Salminen, T Poussa, et al. (2003) Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361 1869.
79. W Zhang, T Leonard, F Bath-Hextall, et al. (2005) Chinese herbal medicine for atopic eczema. Cochrane Database System Review 2 CD002291.
80. PG Unna (1887) Seborrhoeae eczema. J Cutan Dis 5 499.
81. A Krol and B Krafchik (2006) The differential diagnosis of atopic dermatitis in childhood. Dermatol Ther 19 73-82.
82. D Elish and NB Silverberg (2006) Infantile seborrheic dermatitis. Cutis 77 297-300.
83. R Ruiz-Maldonado, R Lopez-Matinez, EL Perez Chavariea, et al. (1989) Pityrosporum ovale in infantile seborrheic dermatitis. Pediatr Dermatol 6 16-20.
84. A Broberg and J Faergemann (1989) Infantile seborrhoeic dermatitis and Pityrosporum ovale. Br J Dermatol 120 359-362.
85. A Zeharia, M Mimouni and D Fogel (1996) Treatment with bifonazole shampoo for scalp seborrhea in infants and young children. Pediatr Dermatol 13 151-153.
86. CB Moises-Alfaro, HW Caceres-Rios, M Rueda, et al. (2002) Are infantile seborrheic and atopic dermatitis clinical variants of the same disease? Int J Dermatol 41 349-351.
87. EA Neville and OA Finn (1975) Psoriasiform napkin dermatitis a follow-up study. Br J Dermatol 92 279-285.
88. L Nall (1994) Epidemiologic strategies in psoriasis research. Int J Dermatol 33 313-319.
89. JT Elder, RP Nair, SW Guo, et al. (1994) The genetics of psoriasis. Arch Dermatol 130 216-224.
90. EM Farber and L Nall (1998) Epidemiology: Natural history and genetics. HH Roenigk, Jr,HI Maibach (Eds) Psoriasis 3rd edn New York: Marcel Dekker
91. S Menni, L Gualandri, D Boccardi, et al. (2006) Association of psoriasis-like eruption and Kawasaki disease. J Dermatol 33 571-573.
92. EM Farber, RH Mullen, AH Jacobs and L Nall (1986) Infantile psoriasis: a follow-up study. Pediatr Dermatol 3 237.
93. N Mozzanica (1992) Pathogenetic aspects of allergic and irritant contact dermatitis. Clin Dermatol 10 115-121.
94. J Stevens and L Lubitz (1998) Symptomatic zinc deficiency in breast-fed term and premature infants. J Paediatr Child Health 34 97-100.
95. AS Prasad (1995) Zinc: an overview. Nutrition 11 93-99.
96. B Lonnerdal, AG Stanislowski and LS Hurley (1980) Isolation of a low molecular weight zinc binding ligand from human milk. J Inorg Biochem 12 71-78.
97. AW Zimmerman, KM Hambidge, ML Lepow, et al. (1982) Acrodermatitis in breast-fed premature infants: Evidence for a defect of mammary zinc secretion. Pediatrics 69 176-183.
98. JP Van Wouwe (1989) Clinical and laboratory diagnosis of acrodermatitis enteropathica. Eur J Pediatr 149 2-8.
99. M Goskowicz and LF Eichenfield (1993) Cutaneous findings of nutritional deficiencies in children. Curr Opin Pediatr 5 441-445.
100. CT Walsh, HH Sandstead, AS Prasad, et al. (1994) Zinc: health effects and research priorities for the 1990s. Environ Health Perspect 102 5-46.
101. B Wolf and GS Heard (1990) Screening for biotinidase deficiency in newborns: worldwide experience. Pediatrics 85 512-517.
102. WL Nyhan (1987) Inborn errors of biotin metabolism. Arch Dermatol 123 1696-1698.
103. J Zempleni and DM Mock (1999) Bioavailability of biotin given orally to humans in pharmacologic doses. Am J Clin Nutr 69 504-508.
104. GL Darmstadt, CP Schmidt, DS Wechsler, et al. (1992) Dermatitis as a presenting sign of cystic fibrosis. Arch Dermatol 128 1358-1364.
105. CP Schmidt and W Tunnessen (1991) Cystic fibrosis presenting with periorificial dermatitis. J Am Acad Dermatol 25 896-897.
106. B Wilcken, JS Yu and DA Brown (1977) Natural history of Hartnup disease. Arch Dis Child 52 38-40.
107. GS Omenn (1965) Familial reticuloendotheliosis with eosinophilia. N Engl J Med 273 427.
108. L Gomez, F Le Deist, S Blanche, et al. (1995) Treatment of Omenn syndrome by bone marrow transplantation. J Pediatr 127 76-81.
109. EB Lee (1983) Metabolic diseases and the skin. Pediatr Clin North Am 30 597-608.
110. E Remold-O'Donnell, DM Kenney, R Parkman, et al. (1984) Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome. J Exp Med 159 1705-1723.
111. HD Ochs (1998) The Wiskott-Aldrich syndrome. Semin Hematol 35 332-345.
112. B Grimbacher, SM Holland, JI Gallin, et al. (1999) Hyper-IgE syndrome with recurrent infections — an autosomal dominant multisystem disorder. N Engl J Med 340 692-702.
113. BM Rudunsky (1963) PR in a 4 month old infant; an account of suggested contagiousness. J Pediatr 62 159-160.
114. HW Hyatt (1960) PR in a 3 month old infant. Arch Pediatr 77 364-368.
115. Y Tay and C Goh (1999) One year review of PR at the National Skin Centre, Singapore. Ann Acad Med Singapore 28 829-831.
116. AS Paller and A Mancini (2006) Hurwitz clinical pediatric dermatology 3rd edn Philadelphia: Elsevier Saunders 101.